R&D

US innovation stimulus a success, says Holdren

John Holdren, Director of the White House Office of Science and Technology, told ScienceBusiness the large one-off increase in science funding in the American Recovery and Reinvestment Act of 2009 has delivered in terms of new facilities and research outputs.

UK cancer charity extends R&D spending

The charity Cancer Research UK confirmed its position as the largest single investor in R&D in the field, announcing it spent a record £333 million on research in its last financial year.